Inhibikase Therapeutics, Inc. — SCHEDULE 13G Filings
3 SCHEDULE 13G filings on record
This page lists all SCHEDULE 13G filings submitted to the SEC by Inhibikase Therapeutics, Inc. (IKT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Inhibikase Therapeutics, Inc. has filed 3 SCHEDULE 13G documents with the SEC since 2018. To view all SEC filings by Inhibikase Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001493152-25-029834 | Dec 31, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-014402 | Feb 14, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-014198 | Feb 14, 2025 | — |